Anteris Technologies Receives FDA Clearance to Initiate Early Feasibility Study for its Novel TAVR Product, DurAVR™
U.S. Clinical Trial Commencement Anticipated in 1Q2023 BRISBANE, Australia & EAGAN, Minn.--(BUSINESS WIRE)--Anteris Technologies Ltd…
U.S. Clinical Trial Commencement Anticipated in 1Q2023 BRISBANE, Australia & EAGAN, Minn.--(BUSINESS WIRE)--Anteris Technologies Ltd…
First-of-its-kind global network will enable improved patient access to advanced precision cancer care, provide leading…
SAN JOSE, Calif.--(BUSINESS WIRE)--Momentus Inc. (NASDAQ: MNTS) ("Momentus" or the "Company"), a U.S. commercial space…
— Study will enrol up to 110 patients in immunotherapy relapsed/refractory RCC and NSCLC —…
SAN JOSE, Calif.--(BUSINESS WIRE)--Momentus Inc. (NASDAQ: MNTS) ("Momentus" or the "Company"), a U.S. commercial space…
SAN JOSE, Calif.--(BUSINESS WIRE)--Momentus Inc. (NASDAQ: MNTS) ("Momentus" or the "Company"), a U.S. commercial space…
DUBLIN--(BUSINESS WIRE)--The "India Automotive Cybersecurity Market: Prospects, Trends Analysis, Market Size and Forecasts up to…
— Study will enrol up to 110 patients in immunotherapy relapsed/refractory RCC and NSCLC —…
NOIDA, India & NEW YORK--(BUSINESS WIRE)--#AI--HCLSoftware, a division of HCL Technologies (HCLTech), launched its new…
NOIDA, India & NEW YORK--(BUSINESS WIRE)--#AI--HCLSoftware, a division of HCL Technologies (HCLTech), launched its new…